Early Life Stress, Chronic Drug Use and Neuroplasticity in Nonhuman Primate Models of Cocaine Abuse: Relevance to Treatment Strategies

非人类灵长类动物滥用可卡因模型中的早期生活压力、慢性吸毒和神经可塑性:与治疗策略的相关性

基本信息

  • 批准号:
    10552042
  • 负责人:
  • 金额:
    $ 80.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

Abstract Despite the risks of adolescent initiation of drug use for lifelong addiction and its tremendous health and societal costs, the neurobiological factors leading to increased vulnerability to substance use disorders (SUDs), including cocaine (COC) use disorder (CUD), are poorly understood. Early life stress (ELS), including adverse experiences such as childhood maltreatment (MALT), is a major risk factor for psychopathologies like SUDs, anxiety and depression, which are often comorbid. Indeed, individuals with histories of childhood MALT are more vulnerable to COC addiction, and deficits in emotional regulation predisposes them to stress-induced relapse, contributing to spiraling of drug taking. Despite these risks, how ELS and COC abuse during adolescence interact to alter brain development, increasing vulnerability to CUD later in life, has not been elucidated. There are also strong sex differences in progression from initiation of drug use during adolescence (experimentation) to the onset of drug dependence, with women showing increased vulnerability, although the underlying neurobiological mechanisms are unclear. The goal of this proposal is to examine long-term ELS- related impact and neurobiological mechanisms of increased risk to CUD during adulthood. To accomplish this, we are using a unique and highly translational nonhuman primate (NHP) model of infant MALT with adolescence COC self-administration (SA) and addressing sex differences. The studies proposed here with a cohort of adult macaques that experienced infant MALT followed by COC SA during adolescence, and characterized longitudinally since birth, are unparalleled. They will provide information of critical relevance for the human HEALthy Brain and Child Development (HBCD) and Adolescent Brain Cognitive Development (ABCD) NIH studies by examining early risk factors and neurobiological mechanisms for SUDs. The studies leverage this unique cohort of animals during adulthood to examine the long-term impact of ELS and adolescence COC SA on neurobiology of reward and stress/emotion regulatory circuits following a year of COC abstinence (Aim 1), neurobiological changes in dopamine (DA) and serotonin (5-HT) receptors and functional connectivity (FC) of prefrontal cortex (PFC) with ventral striatum (nucleus accumbens) and amygdala following re-exposure to COC SA (Aim 2), and the rate of recovery of DA and 5-HT receptors and FC during abstinence from long-term COC, to investigate whether it predicts COC-induced relapse and responses to pharmacological interventions targeting DA and 5-HT receptors; PET data will inform personalized medicine approaches (Aim 3). We hypothesize differential effectiveness of DA and 5-HT receptor compounds (alone vs. mixtures) in MALT than Control animals, and in females versus males. We propose that ELS, in addition to adolescence COC exposure, leads to the dysregulation of reward and stress/emotional systems typically reported in human psychiatric conditions, resulting in increased risk to CUD in adulthood, in comparison to animals with COC adolescence exposure but no ELS history.
摘要 尽管青少年开始使用药物以终身成瘾的风险及其巨大的健康和 社会成本,导致对物质使用障碍(SUD)的脆弱性增加的神经生物学因素, 包括可卡因(COC)使用障碍(CUD),知之甚少。早期生活压力(ELS),包括不良 童年虐待(MALT)等经历,是SUD等精神病理学的主要风险因素, 焦虑和抑郁,这往往是共病。事实上,有童年MALT病史的人 更容易对COC成瘾,情绪调节的缺陷使他们更容易受到压力诱导 复发,导致吸毒螺旋上升。尽管存在这些风险,但ELS和COC在 青少年相互作用,改变大脑发育,增加了在以后的生活中对CUD的脆弱性, 阐明。从青春期开始使用药物的进展也有很大的性别差异 (实验)对药物依赖的发病,妇女表现出更大的脆弱性,虽然 潜在的神经生物学机制尚不清楚。本提案的目标是审查长期ELS- 相关的影响和神经生物学机制的风险增加,以CUD在成年期。为了实现这一点, 我们正在使用一种独特的、高度翻译的非人灵长类动物(NHP)婴儿MALT模型, 青少年COC自我管理(SA)和解决性别差异。这里提出的研究, 在青春期经历婴儿MALT随后COC SA的成年猕猴队列,以及 自出生以来,纵向特征是无与伦比的。它们将提供与下列方面至关重要的信息: 人类健康大脑和儿童发育(HBCD)和青少年大脑认知发育 (ABCD)NIH研究通过检查SUD的早期风险因素和神经生物学机制。 这些研究利用这一独特的成年动物队列来研究ELS的长期影响 和青春期COC SA对奖励和压力/情绪调节电路的神经生物学,经过一年的 COC戒断(目标1),多巴胺(DA)和5-羟色胺(5-HT)受体的神经生物学变化, 前额叶皮层(PFC)与腹侧纹状体(中脑核)的功能连接(FC), 杏仁核后再次暴露于COC SA(目的2),和DA和5-HT受体的恢复率, 长期COC戒断期间的FC,以研究其是否可预测COC诱导的复发, 对针对DA和5-HT受体的药物干预的反应; PET数据将告知 个性化医疗方法(目标3)。我们假设DA和5-HT受体的不同作用 化合物(单独与混合物)在MALT中的作用比对照动物大,并且在雌性动物中比雄性动物大。我们建议 ELS,除了青春期COC暴露外,还导致奖励和压力/情绪调节失调 系统通常报告在人类精神疾病,导致增加的风险,以CUD在成年期, 与青春期暴露于COC但无ELS史的动物进行比较。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael A Nader其他文献

Michael A Nader的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael A Nader', 18)}}的其他基金

Mechanisms Mediating Cocaine Abuse in Socially Housed Female and Male Monkeys
社会饲养的雌性和雄性猴子中调节可卡因滥用的机制
  • 批准号:
    10765789
  • 财政年份:
    2023
  • 资助金额:
    $ 80.87万
  • 项目类别:
Early Life Stress, Chronic Drug Use and Neuroplasticity in Nonhuman Primate Models of Cocaine Abuse: Relevance to Treatment Strategies
非人类灵长类动物滥用可卡因模型中的早期生活压力、慢性吸毒和神经可塑性:与治疗策略的相关性
  • 批准号:
    10380099
  • 财政年份:
    2021
  • 资助金额:
    $ 80.87万
  • 项目类别:
Social Stress: Vulnerability to Cocaine Abuse in Monkeys
社会压力:猴子滥用可卡因的脆弱性
  • 批准号:
    8901420
  • 财政年份:
    2014
  • 资助金额:
    $ 80.87万
  • 项目类别:
Impact of In Utero Cocaine Exposure on Vulnerability to Drug Abuse in Monkeys.
子宫内可卡因暴露对猴子药物滥用脆弱性的影响。
  • 批准号:
    7851300
  • 财政年份:
    2008
  • 资助金额:
    $ 80.87万
  • 项目类别:
Impact of In Utero Cocaine Exposure on Vulnerability to Drug Abuse in Monkeys.
子宫内可卡因暴露对猴子药物滥用脆弱性的影响。
  • 批准号:
    7508208
  • 财政年份:
    2008
  • 资助金额:
    $ 80.87万
  • 项目类别:
Impact of In Utero Cocaine Exposure on Vulnerability to Drug Abuse in Monkeys.
子宫内可卡因暴露对猴子药物滥用脆弱性的影响。
  • 批准号:
    8267115
  • 财政年份:
    2008
  • 资助金额:
    $ 80.87万
  • 项目类别:
Impact of In Utero Cocaine Exposure on Vulnerability to Drug Abuse in Monkeys.
子宫内可卡因暴露对猴子药物滥用脆弱性的影响。
  • 批准号:
    7649473
  • 财政年份:
    2008
  • 资助金额:
    $ 80.87万
  • 项目类别:
Impact of In Utero Cocaine Exposure on Vulnerability to Drug Abuse in Monkeys.
子宫内可卡因暴露对猴子药物滥用脆弱性的影响。
  • 批准号:
    8076363
  • 财政年份:
    2008
  • 资助金额:
    $ 80.87万
  • 项目类别:
Chronic Stress and Cocaine Abuse in Female Monkeys
雌性猴子的慢性压力和可卡因滥用
  • 批准号:
    7228541
  • 财政年份:
    2004
  • 资助金额:
    $ 80.87万
  • 项目类别:
Chronic Stress and Vulnerability to Cocaine Abuse in Female Monkeys
雌性猴子的慢性压力和对可卡因滥用的脆弱性
  • 批准号:
    8238940
  • 财政年份:
    2004
  • 资助金额:
    $ 80.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了